Depression is a serious condition and affects about 10 to 20 percent of pregnant women. One of the most common treatments are selective serotonin reuptake inhibitors, or SSRIs. At one time, the safety of SSRIs treatment during pregnancy and potential risk for the fetus and newborn were unquestioned. However, in the late 2005, of some alarming data concerning possible birth defects began to surface, putting into question the safety of SSRIs on fetuses, according to a review of data by French researchers. These studies showed an increased risk for all congenital malformations with SSRIs and particularly with paroxetine, known by ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.